ISPOR - MT30 Coverage and Payment Implications for Breakthrough Medical Devices Following Translational Coverage of Emerging Technologies (TCET) Proposed Rule in the US

MT30 Coverage and Payment Implications for Breakthrough Medical Devices Following Translational Coverage of Emerging Technologies (TCET) Proposed Rule in the US

Abstract

Authors

A. Chawla Y. Mengesha

Full Text Cite This Article

Back to Volume 26, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now